Finance

Company reports 1Q record revenues

Published in Hepatitis Weekly, June 3rd, 2002

ICN Pharmaceuticals, Inc., (ICN) reported that first quarter revenues were a record $245.7 million compared with $199.0 million in 2001, an increase of 23%.

Operating income in the first quarter was a record $65.8 million compared with $41.2 million, an increase of 60%.

Net income was a record $33.7 million compared with $21.0 million in the first quarter of 2001, an increase of 60%. Earnings per share for the first quarter were $0.40, compared with $0.26, an increase of 54%. Net income included a benefit of $3.5 million from the cumulative effect of change in accounting principle. The company is currently evaluating its remaining goodwill. First...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-06-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry